BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18467999)

  • 1. [Melanoma and non-melanoma skin cancers].
    Saito T
    Gan To Kagaku Ryoho; 2008 Apr; 35(4):583. PubMed ID: 18467999
    [No Abstract]   [Full Text] [Related]  

  • 2. FoxP3 expression on melanoma cells is related to early visceral spreading in melanoma patients treated by electrochemotherapy.
    Quaglino P; Osella-Abate S; Marenco F; Nardò T; Gado C; Novelli M; Savoia P; Bernengo MG
    Pigment Cell Melanoma Res; 2011 Aug; 24(4):734-6. PubMed ID: 21696572
    [No Abstract]   [Full Text] [Related]  

  • 3. Searching for the Achilles' heel of melanoma cells: new treatment modalities.
    Melnikova VO; Bar-Eli M
    Pigment Cell Melanoma Res; 2008 Oct; 21(5):505-6. PubMed ID: 18713130
    [No Abstract]   [Full Text] [Related]  

  • 4. Reactive oxygen species may have antitumor activity in metastatic melanoma.
    Tuma RS
    J Natl Cancer Inst; 2008 Jan; 100(1):11-2. PubMed ID: 18159075
    [No Abstract]   [Full Text] [Related]  

  • 5. Overcoming melanoma drug resistance through metabolic targeting?
    Smalley KS
    Pigment Cell Melanoma Res; 2013 Nov; 26(6):793-5. PubMed ID: 24152044
    [No Abstract]   [Full Text] [Related]  

  • 6. The new arms race against melanoma.
    Lejeune FJ
    Melanoma Res; 2006 Feb; 16(1):1-2. PubMed ID: 16432449
    [No Abstract]   [Full Text] [Related]  

  • 7. How melanoma is treated in real life.
    Dummer R; Schadendorf D
    Arch Dermatol; 2008 May; 144(5):664-5. PubMed ID: 18490596
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular patterns in melanoma and therapeutic targets.
    Chua RA; Arbiser JL
    G Ital Dermatol Venereol; 2010 Oct; 145(5):597-602. PubMed ID: 20930694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reaching first base in the treatment of metastatic melanoma.
    Eggermont AM
    J Clin Oncol; 2006 Oct; 24(29):4673-4. PubMed ID: 16966683
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy for melanoma: the resultant of conflicting vectors.
    Mitchell MS
    J Clin Oncol; 2004 Jun; 22(11):2043-5. PubMed ID: 15123732
    [No Abstract]   [Full Text] [Related]  

  • 11. Metallothionein overexpression, a highly significant prognostic factor in thin melanoma.
    Weinlich G; Zelger B
    Histopathology; 2007 Aug; 51(2):280-3. PubMed ID: 17593214
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolic approaches to treatment of melanoma.
    Hersey P; Watts RN; Zhang XD; Hackett J
    Clin Cancer Res; 2009 Nov; 15(21):6490-4. PubMed ID: 19861452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Melanoma and non-melanoma skin cancer].
    Saida T
    Gan To Kagaku Ryoho; 2015 Apr; 42(4):421. PubMed ID: 26020981
    [No Abstract]   [Full Text] [Related]  

  • 14. [In vitro drug sensitivity profiling in melanoma].
    Ugurel S
    J Dtsch Dermatol Ges; 2008 Jul; 6(7):611. PubMed ID: 18611186
    [No Abstract]   [Full Text] [Related]  

  • 15. Bilateral breast metastases in a pregnant woman with disseminated cutaneous melanoma.
    Mathew M; Burney IA; Al Hamadani A; Rao K
    Indian J Cancer; 2009; 46(4):342-4. PubMed ID: 19749469
    [No Abstract]   [Full Text] [Related]  

  • 16. Stage III melanoma treated with chemotherapy after surgery during the second trimester of pregnancy.
    Ishida I; Yamaguchi Y; Tanemura A; Hosokawa K; Itami S; Morita A; Katayama I
    Arch Dermatol; 2009 Mar; 145(3):346-8. PubMed ID: 19289786
    [No Abstract]   [Full Text] [Related]  

  • 17. [Working group of Dermatologic Oncology ADO. Second-line therapy in stage IV melanoma].
    J Dtsch Dermatol Ges; 2007 Oct; 5(10):959. PubMed ID: 17910683
    [No Abstract]   [Full Text] [Related]  

  • 18. Melanoma or pseudo-melanoma? Change in a pigmented lesion after application of topical 5-Fluorouracil.
    Haeusler KA; Hall JR; Seykora CM; Abuzeid MJ; Dalton SR
    J Cutan Pathol; 2018 Jan; 45(1):97-98. PubMed ID: 29071729
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relationship between the expression of truncated gelsolin and invasiveness in malignant melanoma].
    Furukawa H
    Hokkaido Igaku Zasshi; 2001 May; 76(3):143-50. PubMed ID: 11481867
    [No Abstract]   [Full Text] [Related]  

  • 20. MITF pathway mutations in melanoma.
    Yokoyama S; Salma N; Fisher DE
    Pigment Cell Melanoma Res; 2009 Aug; 22(4):376-7. PubMed ID: 19558635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.